ATE327511T1 - Proteom-analyseverfahren - Google Patents

Proteom-analyseverfahren

Info

Publication number
ATE327511T1
ATE327511T1 AT02729518T AT02729518T ATE327511T1 AT E327511 T1 ATE327511 T1 AT E327511T1 AT 02729518 T AT02729518 T AT 02729518T AT 02729518 T AT02729518 T AT 02729518T AT E327511 T1 ATE327511 T1 AT E327511T1
Authority
AT
Austria
Prior art keywords
proteome analysis
analysis methods
membrane proteins
proteome
interacting
Prior art date
Application number
AT02729518T
Other languages
English (en)
Inventor
Kenji Tanaka
Chuo-Ku Honcho
Lyang-Ja Lee
Hiromichi Mukai
Koji Munechika
Hisashi Arikuni
Mieko Shiwa
Bungo Ochiai
Original Assignee
Protosera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protosera Inc filed Critical Protosera Inc
Application granted granted Critical
Publication of ATE327511T1 publication Critical patent/ATE327511T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02729518T 2001-01-09 2002-01-09 Proteom-analyseverfahren ATE327511T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26043301P 2001-01-09 2001-01-09
US27298101P 2001-03-02 2001-03-02
US10/038,918 US20030044843A1 (en) 2001-01-09 2002-01-03 Novel proteome analysis method and devices therefor

Publications (1)

Publication Number Publication Date
ATE327511T1 true ATE327511T1 (de) 2006-06-15

Family

ID=27365472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02729518T ATE327511T1 (de) 2001-01-09 2002-01-09 Proteom-analyseverfahren

Country Status (10)

Country Link
US (1) US20030044843A1 (de)
EP (1) EP1352249B1 (de)
JP (1) JP4166572B2 (de)
KR (1) KR100853129B1 (de)
CN (1) CN1297820C (de)
AT (1) ATE327511T1 (de)
AU (1) AU2002219562B2 (de)
CA (1) CA2434243C (de)
DE (1) DE60211651T2 (de)
WO (1) WO2002056026A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US20030129666A1 (en) * 2001-01-09 2003-07-10 Mitsubishi Pharma Corporation Novel proteome analysis method and devices therefor
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
AU2003272924B2 (en) * 2002-10-04 2008-05-15 Protosera Inc. Plate for mass spectrometry, process for preparing the same and use thereof
CN1304843C (zh) * 2003-07-02 2007-03-14 许洋 用于生物样品分析的蛋白指纹法
US20050032113A1 (en) * 2003-07-17 2005-02-10 Mitsubishi Pharma Corporation Membrane protein library for proteome analysis and method for preparing same
EP1591783B1 (de) * 2004-04-28 2008-02-20 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Verfahren zum Nachweis und zur Analyse von makromolekularen Komplexen
JP4549803B2 (ja) * 2004-10-08 2010-09-22 富士フイルム株式会社 スクリーニングシステム
SE0403139D0 (sv) * 2004-12-23 2004-12-23 Nanoxis Ab Device and use thereof
US20060266941A1 (en) * 2005-05-26 2006-11-30 Vestal Marvin L Method and apparatus for interfacing separations techniques to MALDI-TOF mass spectrometry
KR100691528B1 (ko) * 2005-06-09 2007-03-09 강원대학교산학협력단 단백질 칩 분석용 표면 플라즈몬 주사 현미경 장치
JP5142458B2 (ja) * 2005-06-30 2013-02-13 キヤノン株式会社 標的物質捕捉分子、標的物質捕捉用の素子、これらを用いた標的物質検出用の装置及びキット、並びに、標的物質の検出方法
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
CN104027359A (zh) 2006-01-23 2014-09-10 阿特西斯公司 无附加的免疫抑制治疗的mapc治疗法
US7879799B2 (en) * 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
US8959448B2 (en) * 2007-04-17 2015-02-17 Emd Millipore Corporation Graphical user interface for analysis and comparison of location-specific multiparameter data sets
EP2548888B1 (de) 2010-03-17 2017-11-01 Kagoshima University Für zahnfleischerkrankungen spezifisches peptid sowie behandlung und diagnose von zahnfleischerkrankungen damit
US9316615B2 (en) * 2010-06-22 2016-04-19 Universal Bio Research Co., Ltd. Device for trapping biologically-relevant substances and system for collecting biologically-relevant substances
DE102011109063B3 (de) 2011-07-28 2012-12-20 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren zum Nachweis von Biomolekülen
CN103135309B (zh) * 2011-11-22 2017-11-17 索尼公司 电泳装置、电泳装置的制造方法、以及显示器
CN103163009A (zh) * 2011-12-14 2013-06-19 天津市国际生物医药联合研究院 鉴定蛋白质的糖基化修饰位点的方法
CN104655737B (zh) * 2013-11-18 2017-02-01 维亚生物科技(上海)有限公司 基于液质联用检测膜蛋白与配体亲和力的混合物筛选方法
WO2015109126A1 (en) * 2014-01-15 2015-07-23 Caliper Life Sciences, Inc. Method and system of microfluidic immunoassay using magnetic beads
WO2019246632A1 (en) * 2018-06-22 2019-12-26 The Regents Of The University Of Colorado A Body Corporate Use of cannabinoids to increase the lipid order of cell membranes
GB201814454D0 (en) 2018-09-05 2018-10-17 Univ Oxford Innovation Ltd Detection of membrane proteins
CN114112980B (zh) * 2022-01-24 2022-05-10 武汉宏韧生物医药股份有限公司 一种基于数据分析的药物组分检测方法与系统

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789734A (en) * 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
US5118937A (en) * 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
DE4017805C2 (de) * 1989-08-22 1998-03-26 Finnigan Mat Gmbh Verfahren, Präparat und Vorrichtung zur Bereitstellung eines Analytes für eine Untersuchung
US5585275A (en) * 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
DE19618032C2 (de) * 1996-05-04 2000-04-13 Bruker Daltonik Gmbh Lagerfähig vorpräparierte Maldi-Probenträger
CN1101440C (zh) * 1998-07-27 2003-02-12 中国科学院长春应用化学研究所 含稀土有机/无机纳米杂化发光材料的合成方法
AU3474100A (en) * 1999-01-25 2000-08-07 Minerva Biotechnologies Corporation Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases

Also Published As

Publication number Publication date
DE60211651T2 (de) 2007-05-10
CA2434243A1 (en) 2002-07-18
JP4166572B2 (ja) 2008-10-15
JP2004518118A (ja) 2004-06-17
KR100853129B1 (ko) 2008-08-20
WO2002056026A1 (en) 2002-07-18
AU2002219562B2 (en) 2006-07-06
CN1297820C (zh) 2007-01-31
EP1352249B1 (de) 2006-05-24
US20030044843A1 (en) 2003-03-06
DE60211651D1 (de) 2006-06-29
KR20030069205A (ko) 2003-08-25
WO2002056026B1 (en) 2002-09-19
CA2434243C (en) 2010-12-07
EP1352249A1 (de) 2003-10-15
CN1496481A (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
ATE327511T1 (de) Proteom-analyseverfahren
IL196902A (en) Collections of capture compounds and methods for analyzing the proteome
DE60124699D1 (de) Zweirichtungs-durchfluss-zentrifugalmikrofluid-vorrichtungen
DK1502102T3 (da) Forbindelser og fremgangsmåder til analysering af proteomet
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
ATE509120T1 (de) Fusionsproteine zur detektion von analyten
ATE418729T1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
AU2002367206A1 (en) Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changes
TW200512457A (en) Method of diagnosing SARS corona virus infection
ATE466659T1 (de) Probenahmesystem mit phosphataseinhibitor
DK1293574T3 (da) Reagenser, fremgangsmåder og indretninger til bestemmelse af analytter
PL1699822T3 (pl) Białka fuzyjne IL-7 z częściami przeciwciała, ich otrzymywanie oraz ich zastosowanie
BR0009206A (pt) Isolamento e análise de proteina
DK1309692T3 (da) Anti-IL12-antistoffer, præparater, fremgangsmåder og anvendelser
NO20033548L (no) Modifiserte proteiner, designer toksiner og fremgangsmåter for fremstillingav disse
ATE410436T1 (de) Bibliothek aus membranproteinen zur analyse des proteoms und verfahren zu deren herstellung
WO2003062402A3 (en) Use of collections of binding sites for sample profiling and other applications
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
WO2002048716A3 (en) Differential phage capture proteomics
EP1780537A4 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE288589T1 (de) Verfahren zur analyse von proteinen
PL1531332T3 (pl) Analiza i typowanie białek monoklonalnych z użyciem elektroforezy kapilarnej i przemieszczenia immunologicznego
ATE365324T1 (de) Nachweis durch serrs in mikrofluidischer umgebung
TW200508936A (en) The establishment of proteome structure profile databases and their uses
IL171913A0 (en) Method of chromatographic analysis of a protein solution

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties